Literature DB >> 9634328

Sensitivity of the ligase chain reaction assay for detecting Chlamydia trachomatis in vaginal swabs from women who are infected at other sites.

B J Thomas1, T Pierpoint, D Taylor-Robinson, A M Renton.   

Abstract

OBJECTIVE: To assess the sensitivity of the ligase chain reaction (LCR) assay for Chlamydia trachomatis in vaginal swabs from women who were positive in cervical samples and/or urines.
SUBJECTS: 413 women attending the genitourinary medicine clinic, St. Mary's Hospital, Paddington.
METHODS: The LCR assay was used to test vaginal swabs from 46 women who were C trachomatis positive at one or both of the other sites by direct fluorescent antibody (DFA) staining, by an enzyme immunoassay (EIA), or by the LCR assay.
RESULTS: The LCR assay of vaginal swabs had the following sensitivity values using confirmed positive results: 93% (41/44) compared with DFA staining of cervical deposits, 93% (41/44) compared with the LCR assay of cervical samples, 93% (28/30) compared with an EIA for cervical samples, 91% (39/43) compared with DFA staining of urine deposits, and 93% (39/42) compared with the LCR assay of urine. Four women had vaginal swab samples negative by the LCR assay; one was positive only in the urine and two had cervical samples containing a small number of chlamydial elementary bodies.
CONCLUSION: Testing vaginal swabs by the LCR assay is a sensitive method of detecting chlamydial infection; the results suggest that this procedure could be used as an alternative to examining urines in a screening programme for chlamydial infection in the community.

Entities:  

Mesh:

Year:  1998        PMID: 9634328      PMCID: PMC1758101          DOI: 10.1136/sti.74.2.140

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  6 in total

1.  Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women.

Authors:  J Schachter; J Moncada; R Whidden; H Shaw; G Bolan; J D Burczak; H H Lee
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

2.  Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis.

Authors:  I P Jensen; P Thorsen; B R Møller
Journal:  Lancet       Date:  1997-02-01       Impact factor: 79.321

3.  Comparison of cervical, urethral, and urine specimens for the detection of Chlamydia trachomatis in women.

Authors:  J W Sellors; J B Mahony; D Jang; L Pickard; C H Goldsmith; A Gafni; M A Chernesky
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

4.  Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study.

Authors:  L Ostergaard; J K Møller; B Andersen; F Olesen
Journal:  BMJ       Date:  1996-11-09

5.  Chlamydia trachomatis in women: the more you look, the more you find.

Authors:  P E Hay; B J Thomas; P J Horner; E MacLeod; A M Renton; D Taylor-Robinson
Journal:  Genitourin Med       Date:  1994-04

6.  Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction.

Authors:  M A Chernesky; D Jang; H Lee; J D Burczak; H Hu; J Sellors; S J Tomazic-Allen; J B Mahony
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

  6 in total
  6 in total

1.  The Use of Molecular Techniques for the Diagnosis and Epidemiologic Study of Sexually Transmitted Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Diagnosing genitourinary chlamydial infection. Vaginal swabs alone may not be sufficient.

Authors:  M H Wilcox; D Subramanian
Journal:  BMJ       Date:  2001-09-01

3.  Assessment of Chlamydia trachomatis prevalence by PCR and LCR in women presenting for termination of pregnancy.

Authors:  S M Garland; S Tabrizi; J Hallo; S Chen
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

4.  Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens.

Authors:  S A Morré; I G Van Valkengoed; R M Moes; A J Boeke; C J Meijer; A J Van den Brule
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

5.  Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard.

Authors:  Carolyn M Black; Jeanne Marrazzo; Robert E Johnson; Edward W Hook; Robert B Jones; Timothy A Green; Julius Schachter; Walter E Stamm; Gail Bolan; Michael E St Louis; David H Martin
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

6.  Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test.

Authors:  Mary-Ann Shafer; Jeanne Moncada; Cherrie B Boyer; Kelli Betsinger; Scott D Flinn; Julius Schachter
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.